Moderna (MRNA) shares dropped nearly 12% following news that FDA official Peter Marks will step down on April 5th, causing uncertainty in the biotech sector, particularly for vaccine makers.

Moderna stock has dropped more than 70% over the past year. The company’s coronavirus vaccine no longer is driving outsized growth -- and Moderna is still in the process of ushering in newer ...

Michael Seibel announced late Wednesday on X that after more than 12 years at the famed accelerator Y Combinator, he is transitioning to a “partner emeritus” role. Y Combinator CEO Garry Tan ...

On March 13, 2025, Portugal's Defense Minister Nuno Melo ruled out replacing its aging fleet of F-16 fighter jets with F-35 Lightning fighter jets, citing concerns about the United States ...

He marked the strike by doing Portugal star Ronaldo's 'sui' celebration. "It was not to mock him or anything, I've always said he has had great importance for me and my football career," Hojlund ...

The S&P 500 lost 4.6%, and the Nasdaq Composite lost 10.4%. Following the trend, shares of Moderna (NASDAQ: MRNA) slid 31.8% in the first three months of the year. More recently, the conspicuous ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments. The facility is the ...

Surely such a subjective question is impossible to answer. Not so. There is an answer, and it is Portugal. To reach this conclusion I received no bribes from the Portuguese tourist board (I am ...

Plan Ahead: Hop on the tram in the middle of its route, such as the Se Cathedral stop, to avoid the long lines at either terminus. San Francisco has its cable cars, London has its red double ...